Life Science Pharmaceuticals
http://investinlife.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Life Science Pharmaceuticals
Ischemix appoints new chief CEO
Clinical-stage biotechnology company Ischemix, which develops cytoprotective compounds to treat cardiovascular and renal conditions, has appointed David DeWahlas president and CEO.
Company Information
- Industry
- Pharmaceuticals
-
Biotechnology
- Large Molecule
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice